These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 197361

  • 1. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD, Fields JZ, Yamamura HI.
    Life Sci; 1977 Aug 01; 21(3):335-43. PubMed ID: 197361
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M, Ploska A, Javoy-Agid F, Agid Y.
    Brain Res; 1982 Jan 28; 232(1):129-39. PubMed ID: 7055689
    [Abstract] [Full Text] [Related]

  • 5. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease.
    Griffiths PD, Sambrook MA, Perry R, Crossman AR.
    J Neurol Sci; 1990 Dec 28; 100(1-2):131-6. PubMed ID: 1965202
    [Abstract] [Full Text] [Related]

  • 6. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ, Ferkany JW, Strong R.
    Adv Biochem Psychopharmacol; 1980 Dec 28; 21():253-63. PubMed ID: 6246740
    [No Abstract] [Full Text] [Related]

  • 7. Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
    Ahlskog JE, Richelson E, Nelson A, Kelly PJ, Okazaki H, Tyce GM, van Heerden JA, Stoddard SL, Carmichael SW.
    Ann Neurol; 1991 Aug 28; 30(2):185-91. PubMed ID: 1654766
    [Abstract] [Full Text] [Related]

  • 8. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
    Nordberg A, Nyberg P, Adolfsson R, Winblad B.
    J Neural Transm; 1987 Aug 28; 69(1-2):19-32. PubMed ID: 3585318
    [Abstract] [Full Text] [Related]

  • 9. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW, Wells FR, Jenner P, Marsden CD.
    J Neurochem; 1993 Jan 28; 60(1):197-203. PubMed ID: 8417140
    [Abstract] [Full Text] [Related]

  • 10. Environmental enrichment and neurotransmitter receptors.
    Por SB, Bennett EL, Bondy SC.
    Behav Neural Biol; 1982 Feb 28; 34(2):132-40. PubMed ID: 6123308
    [No Abstract] [Full Text] [Related]

  • 11. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ.
    Ann Neurol; 1985 Aug 28; 18(2):202-10. PubMed ID: 2994554
    [Abstract] [Full Text] [Related]

  • 12. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L, Desnos C, Blin J, Raisman R, Scherman D, Javoy-Agid F, Ruberg M, Agid Y.
    J Neurol Sci; 1988 Sep 28; 86(2-3):291-306. PubMed ID: 2975699
    [Abstract] [Full Text] [Related]

  • 13. Alterations in brain opiate receptors in Parkinson's disease.
    Reisine TD, Rossor M, Spokes E, Iversen LL, Yamamura HI.
    Brain Res; 1979 Sep 14; 173(2):378-82. PubMed ID: 226215
    [No Abstract] [Full Text] [Related]

  • 14. Gamma-aminobutyric acid receptor binding in human brain regions.
    Van Ness PC, Olsen RW.
    J Neurochem; 1979 Aug 14; 33(2):593-6. PubMed ID: 224147
    [No Abstract] [Full Text] [Related]

  • 15. Evidence for transient perinatal glutamatergic innervation of globus pallidus.
    Greenamyre T, Penney JB, Young AB, Hudson C, Silverstein FS, Johnston MV.
    J Neurosci; 1987 Apr 14; 7(4):1022-30. PubMed ID: 2883265
    [Abstract] [Full Text] [Related]

  • 16. Alterations in dopaminergic receptors in Huntington's disease.
    Reisine TD, Fields JZ, Stern LZ, Johnson PC, Bird ED, Yamamura HI.
    Life Sci; 1977 Oct 15; 21(8):1123-8. PubMed ID: 144230
    [No Abstract] [Full Text] [Related]

  • 17. Proceedings: Para-o-methylation of dopamine in human brain.
    Ebinger G, Verheyden R.
    Acta Neurol Belg; 1975 Oct 15; 75(2):111. PubMed ID: 1155020
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease: low density and presynaptic location of D3 dopamine receptors.
    Lee T, Seeman P, Hornykiewicz O, Bilbao J, Deck J, Tourtellotte WW.
    Brain Res; 1981 May 18; 212(2):494-8. PubMed ID: 7225883
    [No Abstract] [Full Text] [Related]

  • 19. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ.
    Life Sci; 1977 Jan 15; 20(2):205-11. PubMed ID: 190505
    [No Abstract] [Full Text] [Related]

  • 20. Transmitter receptor alterations in Parkinson's disease.
    Calne DB, Stoessl AJ.
    Adv Neurol; 1987 Jan 15; 45():45-9. PubMed ID: 2881449
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.